Department of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064 and Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine, Peoria, IL 61605, USA.
Evid Based Complement Alternat Med. 2010 Jun;7(2):203-12. doi: 10.1093/ecam/nem159. Epub 2007 Dec 26.
Catalytic therapy (CT) is a cancer treatment modality based on the generation of reactive oxygen species (ROS) using a combination of substrate molecules and a catalyst. The most frequently used substrate/catalyst pair is ascorbate/Co phthalocyanine (PcCo). In the present work, herb extracts containing pigments have been studied as a catalyst in place of PcCo. Extracts from herbs are expected to have efficiency comparable with that of phthalocyanines but as natural products, to exhibit fewer side effects. The present studies demonstrate that a combined use of ascorbate and herbal extracts results in ROS production and a significant decrease in the number of cancer cells after a single in vitro treatment. Treatment with ascorbate in conjunction with extracts prepared from several medicinal herbs stimulated apoptosis and disrupted the cell cycle. The number of cells accumulating in the sub-G0/G1 stage of the cell cycle was increased 2- to 7-fold, and cells in G(2)/M increased 1.5- to 20-fold, indicating that the treatment protocol was highly effective in suppressing DNA synthesis and potentially reflecting DNA damage in the tumor cells. In addition, 20-40% of the cells underwent apoptosis within 24 h of completing treatment. Our results suggest that herbal extracts can function as CT catalysts in the treatment of cancer.
催化疗法(CT)是一种基于使用底物分子和催化剂产生活性氧物种(ROS)的癌症治疗方式。最常用的底物/催化剂对是抗坏血酸/钴酞菁(PcCo)。在本工作中,已研究了含有色素的草药提取物作为替代 PcCo 的催化剂。预计草药提取物的效率可与酞菁相当,但作为天然产物,其副作用较少。目前的研究表明,抗坏血酸与草药提取物联合使用可导致 ROS 产生,并在单次体外治疗后显著减少癌细胞数量。与几种药用草药提取物联合使用的抗坏血酸处理可刺激细胞凋亡并破坏细胞周期。细胞周期中 S 期和 G1 期的细胞数量增加了 2 至 7 倍,G2/M 期的细胞增加了 1.5 至 20 倍,这表明该治疗方案在抑制 DNA 合成方面非常有效,并且可能反映了肿瘤细胞中的 DNA 损伤。此外,在完成治疗后的 24 小时内,有 20%-40%的细胞发生了细胞凋亡。我们的结果表明,草药提取物可以作为癌症治疗中的 CT 催化剂。